Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessia Balestrino
Observed name:
Alessia BALESTRINO
Institution:
University of Salerno
Observed institution:
University of Salerno
ORCID:
0009-0007-1982-7031
Observed ORCID:
0009-0007-1982-7031
OpenAlex ID:
A5015574982
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients
2025
·
Annunziata Raimondo
, Alessia Balestrino
, et al.
·
Life
·
4
Silk Sericin Functionalized with Carboxy Drugs for Dermocosmetic Applications
2026
·
Rita Argenziano
, Alessia Balestrino
, et al.
·
ACS Applied Bio Materials
·
2
PDF
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis
2023
·
Annunziata RAIMONDO
, Alessia BALESTRINO
, et al.
·
Italian Journal of Dermatology and Venereology
·
2
AUF‐1 and skin inflammation: Atopic dermatitis and psoriasis
2023
·
Serena Lembo
, Annunziata Raimondo
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
1
Apremilast, Methotrexate and NB ‐ UVB Phototherapy for Moderate to Severe Psoriasis: Efficacy, Safety, and Immunomodulation in Comparison
2025
·
Alessia Balestrino
, Serena Lembo
, et al.
·
Photodermatology Photoimmunology & Photomedicine
ESDR121 - Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker.
2022
·
Annunziata Raimondo
, Alessia Balestrino
, et al.
Show more works
View as search
Works count:
6
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type